What are the Key Facts About Tuberculosis? is a key topic under Science And Technology for UPSC Civil Services Examination. Key points include: Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis, primarily affecting the lungs.. It spreads through airborne droplets from coughing, sneezing, or spitting.. Common symptoms include prolonged cough, chest pain, weight loss, fever, and night sweats.. Understanding this topic is essential for both UPSC Prelims and Mains preparation.
What are the Key Facts About Tuberculosis? is a Medium-level topic in UPSC Science And Technology. It is tested in both Prelims (factual MCQs) and Mains (analytical answer writing). Previous year UPSC questions have frequently covered aspects of What are the Key Facts About Tuberculosis?, making it essential for comprehensive IAS preparation.
To prepare What are the Key Facts About Tuberculosis? for UPSC: (1) Study the comprehensive notes covering all key concepts on Vaidra. (2) Practice previous year questions on this topic. (3) Connect it with current affairs using daily updates. (4) Revise using key takeaways and mind maps available for Science And Technology. (5) Write practice answers linking What are the Key Facts About Tuberculosis? to related GS Paper topics.

Tuberculosis (TB) is a severe infectious disease. It is primarily caused by the bacterium Mycobacterium tuberculosis. This disease predominantly targets the lungs, making it a significant public health concern.
Causative Agent: The infectious agent responsible for TB is the bacterium Mycobacterium tuberculosis.
TB spreads through the air, making it highly contagious. When an infected individual performs actions like coughing, sneezing, or spitting, tiny droplets containing the bacteria are released into the atmosphere, which can then be inhaled by others.
The symptoms of TB can vary but often include a range of debilitating signs. Recognizing these symptoms is crucial for early diagnosis and treatment.
Certain conditions and lifestyle choices can significantly increase an individual's susceptibility to developing active TB disease after exposure to the bacteria.
Effective prevention involves a multi-pronged approach, focusing on early detection and vaccination.
BCG Vaccine: The Bacille Calmette-Guérin (BCG) vaccine is crucial for preventing severe forms of TB, particularly in children. It primarily helps prevent TB outside the lungs (e.g., TB meningitis, disseminated TB) but offers limited protection against pulmonary TB in adults.
Tuberculosis remains a global health challenge due to its widespread prevalence and the complexities of its treatment.
Global Prevalence: Approximately 25% of the global population is estimated to be infected with TB bacteria. Out of these, about 5-10% of infections typically progress to active TB disease.
Curability: Despite its severity, TB is both preventable and curable. Treatment involves a regimen of specific antibiotics.
Standard treatment for active TB disease involves a combination of antibiotics, typically administered over several months to ensure complete eradication of the bacteria.
First-line Anti-TB Drugs: The primary antibiotics used in standard TB treatment include isoniazid, rifampin, pyrazinamide, ethambutol, and sometimes streptomycin.
A significant challenge in TB control is the emergence of drug-resistant strains, particularly Multidrug-resistant TB (MDR-TB).
MDR-TB Definition: MDR-TB is a form of tuberculosis caused by bacteria that are resistant to at least the two most potent first-line anti-TB drugs: isoniazid and rifampin.
Treating MDR-TB is considerably more complex and resource-intensive. It requires the use of second-line drugs, which are often more costly, have more severe side effects, and require longer treatment durations.


TDB ने Acrannolife Genomics को चेन्नई में स्वदेशी IVD किट निर्माण सुविधा स्थापित करने के लिए वित्तीय सहायता प्रदान की
17 Mar 2026
PM Modi Calls for Austerity‑Style Behavioural Changes Amid Oil‑Price Shock – What It Means for India
4 Jun 2026
Watch: Karnataka CM change: Siddaramaiah resigns, what’s next? | Above the Fold | 28.05.2026
28 May 2026
Knowledge Nugget: What makes GalaxEye’s Drishti satellite first of its kind?
11 May 2026